Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario

SIMPLE SUMMARY: Immune checkpoint inhibitors currently represent the standard of care for the treatment of different tumor types and have also been proven to be effective in several disease settings. However, their use is associated with a peculiar toxicity profile, related to the enhancement of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Spagnolo, Calogera Claudia, Giuffrida, Giuseppe, Cannavò, Salvatore, Franchina, Tindara, Silvestris, Nicola, Ruggeri, Rosaria Maddalena, Santarpia, Mariacarmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818218/
https://www.ncbi.nlm.nih.gov/pubmed/36612243
http://dx.doi.org/10.3390/cancers15010246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818218/
https://www.ncbi.nlm.nih.gov/pubmed/36612243
http://dx.doi.org/10.3390/cancers15010246

Ejemplares similares